Selected research
Market Structure
Global Duloxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Duloxetine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Duloxetine include Teva, Sun Pharma, Eli Lilly, Zydus Pharmaceuticals, Jiangsu Nhwa Pharmaceutical, Torrent Pharmaceuticals, MACLEODS, Lupin and CSPC Ouyi Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Duloxetine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Duloxetine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Duloxetine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Duloxetine market size, projected growth trends, production technologies, key applications, and end-use industries.
Duloxetine Segment by Company
Teva
Sun Pharma
Eli Lilly
Zydus Pharmaceuticals
Jiangsu Nhwa Pharmaceutical
Torrent Pharmaceuticals
MACLEODS
Lupin
CSPC Ouyi Pharm
Breckenridge
Aurobindo Pharma
Apotex
Ajanta Pharma
Duloxetine Segment by Type
60mg Capsules
40mg Capsules
30mg Capsules
20mg Capsules
Duloxetine Segment by Application
Hospital
Drug store
Duloxetine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duloxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Duloxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duloxetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Duloxetine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Duloxetine industry.
Chapter 3: Detailed analysis of Duloxetine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Duloxetinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 60mg Capsules
- 40mg Capsules
- 30mg Capsules
- 20mg Capsules
Applications
- Hospital
- Drug store
Companies covered
- Teva
- Sun Pharma
- Eli Lilly
- Zydus Pharmaceuticals
- Jiangsu Nhwa Pharmaceutical
- Torrent Pharmaceuticals
- MACLEODS
- Lupin
- CSPC Ouyi Pharm
- Breckenridge
- Aurobindo Pharma
- Apotex
- Ajanta Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Duloxetine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 60mg Capsules
- 1.2.3 40mg Capsules
- 1.2.4 30mg Capsules
- 1.2.5 20mg Capsules
- 1.3 Market Analysis by Application
- 1.3.1 Global Duloxetine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Global Market Growth Prospects
- 1.5 Global Duloxetine Growth Trends by Region
- 1.5.1 Global Duloxetine Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Duloxetine Market Size by Region (2021-2026)
- 1.5.3 Duloxetine Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Duloxetine Market Dynamics
- 2.1 Duloxetine Industry Trends
- 2.2 Duloxetine Industry Drivers
- 2.3 Duloxetine Industry Opportunities and Challenges
- 2.4 Duloxetine Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Duloxetine Revenue by Company (2021-2026)
- 3.2 Global Duloxetine Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Duloxetine Key Company Head office and Area Served
- 3.4 Global Duloxetine Company, Product Type & Application
- 3.5 Global Duloxetine Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Duloxetine Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Duloxetine Players Market Share by Revenue in 2025
- 3.6.3 2025 Duloxetine Tier 1, Tier 2, and Tier 3
4 Duloxetine Market by Type
- 4.1 Global Duloxetine Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Duloxetine Market Size by Type (2021-2032)
- 4.3 Global Duloxetine Market Size Share by Type (2021-2032)
5 Duloxetine Market by Application
- 5.1 Global Duloxetine Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Duloxetine Market Size by Application (2021-2032)
- 5.3 Global Duloxetine Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Teva Duloxetine Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sun Pharma
- 6.2.1 Sun Pharma Company Information
- 6.2.2 Sun Pharma Business Overview
- 6.2.3 Sun Pharma Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Sun Pharma Duloxetine Product Portfolio
- 6.2.5 Sun Pharma Recent Developments
- 6.3 Eli Lilly
- 6.3.1 Eli Lilly Company Information
- 6.3.2 Eli Lilly Business Overview
- 6.3.3 Eli Lilly Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Eli Lilly Duloxetine Product Portfolio
- 6.3.5 Eli Lilly Recent Developments
- 6.4 Zydus Pharmaceuticals
- 6.4.1 Zydus Pharmaceuticals Company Information
- 6.4.2 Zydus Pharmaceuticals Business Overview
- 6.4.3 Zydus Pharmaceuticals Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Zydus Pharmaceuticals Duloxetine Product Portfolio
- 6.4.5 Zydus Pharmaceuticals Recent Developments
- 6.5 Jiangsu Nhwa Pharmaceutical
- 6.5.1 Jiangsu Nhwa Pharmaceutical Company Information
- 6.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 6.5.3 Jiangsu Nhwa Pharmaceutical Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Jiangsu Nhwa Pharmaceutical Duloxetine Product Portfolio
- 6.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 6.6 Torrent Pharmaceuticals
- 6.6.1 Torrent Pharmaceuticals Company Information
- 6.6.2 Torrent Pharmaceuticals Business Overview
- 6.6.3 Torrent Pharmaceuticals Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Torrent Pharmaceuticals Duloxetine Product Portfolio
- 6.6.5 Torrent Pharmaceuticals Recent Developments
- 6.7 MACLEODS
- 6.7.1 MACLEODS Company Information
- 6.7.2 MACLEODS Business Overview
- 6.7.3 MACLEODS Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 MACLEODS Duloxetine Product Portfolio
- 6.7.5 MACLEODS Recent Developments
- 6.8 Lupin
- 6.8.1 Lupin Company Information
- 6.8.2 Lupin Business Overview
- 6.8.3 Lupin Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lupin Duloxetine Product Portfolio
- 6.8.5 Lupin Recent Developments
- 6.9 CSPC Ouyi Pharm
- 6.9.1 CSPC Ouyi Pharm Company Information
- 6.9.2 CSPC Ouyi Pharm Business Overview
- 6.9.3 CSPC Ouyi Pharm Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 CSPC Ouyi Pharm Duloxetine Product Portfolio
- 6.9.5 CSPC Ouyi Pharm Recent Developments
- 6.10 Breckenridge
- 6.10.1 Breckenridge Company Information
- 6.10.2 Breckenridge Business Overview
- 6.10.3 Breckenridge Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Breckenridge Duloxetine Product Portfolio
- 6.10.5 Breckenridge Recent Developments
- 6.11 Aurobindo Pharma
- 6.11.1 Aurobindo Pharma Company Information
- 6.11.2 Aurobindo Pharma Business Overview
- 6.11.3 Aurobindo Pharma Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Aurobindo Pharma Duloxetine Product Portfolio
- 6.11.5 Aurobindo Pharma Recent Developments
- 6.12 Apotex
- 6.12.1 Apotex Company Information
- 6.12.2 Apotex Business Overview
- 6.12.3 Apotex Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Apotex Duloxetine Product Portfolio
- 6.12.5 Apotex Recent Developments
- 6.13 Ajanta Pharma
- 6.13.1 Ajanta Pharma Company Information
- 6.13.2 Ajanta Pharma Business Overview
- 6.13.3 Ajanta Pharma Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Ajanta Pharma Duloxetine Product Portfolio
- 6.13.5 Ajanta Pharma Recent Developments
7 North America
- 7.1 North America Duloxetine Market Size (2021-2032)
- 7.2 North America Duloxetine Market Size by Type
- 7.2.1 North America Duloxetine Market Size by Type (2021-2026)
- 7.2.2 North America Duloxetine Market Size by Type (2027-2032)
- 7.2.3 North America Duloxetine Market Share by Type (2021-2032)
- 7.3 North America Duloxetine Market Size by Application
- 7.3.1 North America Duloxetine Market Size by Application (2021-2026)
- 7.3.2 North America Duloxetine Market Size by Application (2027-2032)
- 7.3.3 North America Duloxetine Market Share by Application (2021-2032)
- 7.4 North America Duloxetine Market Size by Country
- 7.4.1 North America Duloxetine Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Duloxetine Market Size by Country (2021-2026)
- 7.4.3 North America Duloxetine Market Size by Country (2027-2032)
- 7.4.4 North America Duloxetine Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Duloxetine Market Size (2021-2032)
- 8.2 Europe Duloxetine Market Size by Type
- 8.2.1 Europe Duloxetine Market Size by Type (2021-2026)
- 8.2.2 Europe Duloxetine Market Size by Type (2027-2032)
- 8.2.3 Europe Duloxetine Market Share by Type (2021-2032)
- 8.3 Europe Duloxetine Market Size by Application
- 8.3.1 Europe Duloxetine Market Size by Application (2021-2026)
- 8.3.2 Europe Duloxetine Market Size by Application (2027-2032)
- 8.3.3 Europe Duloxetine Market Share by Application (2021-2032)
- 8.4 Europe Duloxetine Market Size by Country
- 8.4.1 Europe Duloxetine Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Duloxetine Market Size by Country (2021-2026)
- 8.4.3 Europe Duloxetine Market Size by Country (2027-2032)
- 8.4.4 Europe Duloxetine Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Duloxetine Market Size (2021-2032)
- 9.2 China Duloxetine Market Size by Type
- 9.2.1 China Duloxetine Market Size by Type (2021-2026)
- 9.2.2 China Duloxetine Market Size by Type (2027-2032)
- 9.2.3 China Duloxetine Market Share by Type (2021-2032)
- 9.3 China Duloxetine Market Size by Application
- 9.3.1 China Duloxetine Market Size by Application (2021-2026)
- 9.3.2 China Duloxetine Market Size by Application (2027-2032)
- 9.3.3 China Duloxetine Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Duloxetine Market Size (2021-2032)
- 10.2 Asia Duloxetine Market Size by Type
- 10.2.1 Asia Duloxetine Market Size by Type (2021-2026)
- 10.2.2 Asia Duloxetine Market Size by Type (2027-2032)
- 10.2.3 Asia Duloxetine Market Share by Type (2021-2032)
- 10.3 Asia Duloxetine Market Size by Application
- 10.3.1 Asia Duloxetine Market Size by Application (2021-2026)
- 10.3.2 Asia Duloxetine Market Size by Application (2027-2032)
- 10.3.3 Asia Duloxetine Market Share by Application (2021-2032)
- 10.4 Asia Duloxetine Market Size by Country
- 10.4.1 Asia Duloxetine Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Duloxetine Market Size by Country (2021-2026)
- 10.4.3 Asia Duloxetine Market Size by Country (2027-2032)
- 10.4.4 Asia Duloxetine Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Duloxetine Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Duloxetine Market Size by Type
- 11.2.1 South America, Middle East & Africa Duloxetine Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Duloxetine Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Duloxetine Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Duloxetine Market Size by Application
- 11.3.1 South America, Middle East & Africa Duloxetine Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Duloxetine Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Duloxetine Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Duloxetine Market Size by Country
- 11.4.1 South America, Middle East & Africa Duloxetine Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Duloxetine Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Duloxetine Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Duloxetine Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst